US FDA update on nitrosamine impurities investigation

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2019年 / 1739卷 / 1期

关键词：

D O I：

10.1007/s40278-019-57642-9

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：2 / 2

相关论文

共 50 条

[1] NITROSAMINE UPDATE - FDA FINDINGS DEEPEN CRISIS
不详
DRUG & COSMETIC INDUSTRY, 1978, 122 (03): : 24 - &
[2] NITROSAMINE UPDATE ... II - FDA ASSAYS REGULATORY ALERT
不详
DRUG & COSMETIC INDUSTRY, 1978, 123 (02): : 32 - &
[3] EMA issues update on nitrosamine impurities in EU medicines
Reactions Weekly, 2020, 1795 (1) : 2 - 2
[4] Nitrosamine impurities in metformin
Reactions Weekly, 2019, 1784 (1) : 6 - 6
[5] Update on the Office of Drug Safety at the US FDA
Reactions Weekly, 2004, 1015 (1) : 3 - 4
[6] Nitrosamine impurities in 'sartans' in Australia
Reactions Weekly, 2019, 1772 (1) : 2 - 2
[7] Impurity Testing of Ranitidine Products: US FDA Update
不详
PHARMACEUTICAL MEDICINE, 2020, 34 (01) : 70 - 70
[8] Impurity testing of ranitidine products: US FDA update
Reactions Weekly, 2019, 1779 (1) : 1 - 1
[9] US FDA calls for antidepressant 'black box' update
Reactions Weekly, 2007, 1151 (1) : 3 - 3
[10] US FDA issues reminder to update NSAID labelling
Reactions Weekly, 2005, 1057 (1) : 3 - 3

← 1 2 3 4 5 →